Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN1A | P35498 | 2/20 | 0.39 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.39 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 5/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.33 |
| ▸ | HTR1A | P08908 | 2/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21352710 | 0.77 | SCN1A (0.43) | SCN1ASCN2ASCN3ACHRM5CHRM1 | |
| SCHEMBL1149415 | 0.75 | SCN1A (0.42) | SCN1ASCN2ASCN3ACHRM5CHRM1 | |
| Fluoromethane SCHEMBL27938158 | 0.74 | SCN1A (0.38) | SCN1ASCN2ASCN3ACHRM5CHRM1 | |
| SCHEMBL12096236 | 0.71 | SCN1A (0.39) | SCN1ASCN2ASCN3ACHRM5CHRM1 | |
| Hydrochloric Acid SCHEMBL28511733 | 0.70 | CHRM1 (0.37) | SCN1ASCN2ASCN3ACHRM5CHRM1 | |
| SCHEMBL5944501 | 0.69 | SCN1A (0.45) | SCN1ASCN2ASCN3ACHRM5CHRM1 | |
| SCHEMBL15227423 | 0.68 | — | — | |
| Hydrochloric Acid SCHEMBL22409396 | 0.67 | SCN1A (0.43) | SCN1ASCN2ASCN3ACHRM5CHRM1 | |
| Hydrochloric Acid SCHEMBL28431629 | 0.67 | SCN1A (0.43) | SCN1ASCN2ASCN3ACHRM5CHRM1 | |
| SCHEMBL13640658 | 0.67 | SCN1A (0.36) | SCN1ASCN2ASCN3ACHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150367005-A1 | METHOD OF SYNTHESIZING FLUORINE-18 LABELED RADIOPHARMACEUTICALS IN ETHANOL AND WATER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2015-12-24 | — | — | US | claimed |
| CN-101094824-B | Method for preparation of organofluoro compounds in alcohol solvents | FUTURECHEM CO LTD (KR) | 2011-07-27 | — | — | CN | claimed |
| US-20080171863-A1 | Method for Preparing of Organofluoro Compounds in Alcohol Solvents | FUTURECHEM CO., LTD. (KR) | 2008-07-17 | — | — | US | claimed |
| CN-101094824-A | Method for preparation of organofluoro compounds in alcohol solvents | ASAN FOUNDATION (KR) | 2007-12-26 | — | — | CN | claimed |
| US-20150367005-A1 | METHOD OF SYNTHESIZING FLUORINE-18 LABELED RADIOPHARMACEUTICALS IN ETHANOL AND WATER | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2015-12-24 | — | — | US | disclosed |
| CN-101094824-B | Method for preparation of organofluoro compounds in alcohol solvents | FUTURECHEM CO LTD (KR) | 2011-07-27 | — | — | CN | disclosed |
| US-20080171863-A1 | Method for Preparing of Organofluoro Compounds in Alcohol Solvents | FUTURECHEM CO., LTD. (KR) | 2008-07-17 | — | — | US | disclosed |
| CN-101094824-A | Method for preparation of organofluoro compounds in alcohol solvents | ASAN FOUNDATION (KR) | 2007-12-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171863-A1 | Method for Preparing of Organofluoro Compounds in Alcohol Solvents | ADH5, ADH1C, ADH1A | SCN1A 1668/4885SCN2A 2667/4885SCN3A 1433/4885 |
| US-20150367005-A1 | METHOD OF SYNTHESIZING FLUORINE-18 LABELED RADIOPHARMACEUTICALS IN ETHANOL AND WATER | TMEM14C, ADH1A, SELENOI | SCN1A 2187/4885SCN2A 2106/4885SCN3A 1519/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.